Abstract
Both hyperuricemia and echocardiographically determined left ventricular (LV) mass have a well-determined association with cardiovascular morbidity and mortality. However, whether or not there is a sex difference in the association of serum uric acid level with LV mass has never been systematically explored. We examined the sex-specific relation of serum uric acid level and echocardiographic indexes of LV structure in never-treated patients with essential hypertension. We enrolled 160 never-treated hypertensive patients (89 men and 71 women) to assess the possible relationship between LV mass and serum uric acid levels. LV measurements were performed according to the recommendations of the American Society of Echocardiography and the Penn Convention. LV mass was indexed by height, body surface area and height raised to the 2.7th power. A positive significant correlation between LV geometry (LV mass, indexed LV mass and relative wall thickness) and serum uric acid level was found in male hypertensive patients but not in female hypertensive patients. Independent determinants of serum uric acid levels in male hypertensive patients were LV mass and serum creatinine levels. In addition, male hypertensive patients with concentric hypertrophy showed the highest serum uric acid levels. In comparison, independent determinants of serum uric acid levels in female hypertensive patients were age and serum creatinine levels. In conclusion, these findings indicate a sex difference in the association of uric acid with LV geometry in Japanese hypertensive patients. In addition, the finding that the highest levels of serum uric acid were observed in our male hypertensive patients with concentric hypertrophy confirmed the previous reports that these patients have the highest risk for cardiovascular morbidity and mortality.
Similar content being viewed by others
Article PDF
References
Gertler MM, Garn SM, Levine SA : Serum uric acid in relation to age and physique in health and in coronary heart disease. Ann Intern Med 1951; 34: 1421–1431.
Brand FN, McGee DL, Kannel WB, Stokes J, Castelli WP : Hyperuricemia as a risk factor of coronary heart disease: the Framingham Study. Am J Epidemiol 1985; 121: 11–18.
Abbott RD, Brand FN, Kannel WB, Castelli WP : Gout and coronary disease: the Framingham Study. J Clin Epidemiol 1988; 41: 237–242.
Levine W, Dyer AR, Shekelle RB, Shekelle RB, Schoenberger JA, Stamler J : Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industory. J Clin Epidemiol 1989; 42: 257–267.
Nakanishi N, Tatara K, Nakamura K, Suzuki K : Risk factors for the incidence of hyperuricemia: a 6-year longitudinal study of middle-aged Japanese men. Int J Epidemiol 1999; 28: 888–893.
Franse LV, Pahor M, DiBari M, et al: Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP). J Hypertens 2000; 18: 1149–1554.
Inoue T, Matsuoka M, Nagahama K, et al: Cardiovascular risk factors associated with pulse pressure in screened cohort in Okinawa, Japan. Hypertens Res 2003; 26: 153–158.
Nagahama K, Iseki K, Inoue T, Touma T, Ikemiya Y, Takishita S : Hyperuicemia and cardiovascular risk factor clustering in a screened cohort in Okinawa, Japan. Hypertens Res 2004; 27: 227–233.
Casale PN, Devereux RB, Milner M, et al: Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105: 173–178.
Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH : Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345–352.
Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP : Left ventricular mass and incidence of coronary heart disease in an elderly cohort: the Framingham Heart Study. Ann Intern Med 1989; 110: 101–107.
Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP : Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561–1566.
Shigematsu Y, Hamada M, Mukai M, Matsuoka H, Sumimoto T, Hiwada K : Clinical evidence for an association between left ventricular geometric adaptation and extracardiac target organ damage in essential hypertension. J Hypertens 1995; 13: 155–160.
Shigematsu Y, Hamada M, Ohtsuka T, et al: Left ventricular geometry as an independent predictor for extracardiac target organ damage in essential hypertension. Am J Hypertens 1998; 11: 1171–1177.
Cuspidi C, Meani S, Salerno M, et al: Cardiovascular target organ damage in essential hypertensive with or without reproducible nocturnal fall in blood pressure. J Hypertens 2004; 22: 273–280.
Japanese Society of Hypertension Guideline Subcommittee for the Management of Hypertension: Guideline for the management of hypertension for general practitioners. Hypertens Res 2001; 24: 613–634.
Shigematsu Y, Hamada M, Okayama H, et al: Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism. Hypertension 1997; 29: 723–727.
Sahn DJ, DeMaria A, Kisslo J, Weyman A : The Committee on M-Mode Standardization of the American Society of Echocardiography: Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072–1083.
Devereux RB, Reichek N : Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55: 613–618.
Dubin J, Wallerson DC, Cody RJ, Devereux RB : Comparative accuracy of Doppler methods for clinical stroke volume determinations. Am Heart J 1990; 120: 116–123.
Freedman DS, Williamson DF, Gunter EW, Byers T : Relation of serum uric acid to mortality and ischemic heart disease: the NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1995; 141: 637–644.
de Simone G, Devereux RB, Daniels SR, Koren MJ, Meyer RA, Laragh JH : Effect of growth on variability of left ventricular mass: assessment of allometric signals in adult and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol 1995; 25: 1056–1062.
Levy D, Savage DD, Garrison RJ, Anderson D, Kannel WB, Castelli WP : Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol 1997; 59: 956–960.
Culleton BF, Larson MG, Kannel WB, Levy D : Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999; 131: 7–13.
Fang J, Alderman MH : Serum uric acid and cardiovascular motality: the NHANES I Epidemiologic Follow-up Study, 1971–1992. JAMA 2000; 283: 2404–2410.
Gerstenblith G, Frederiksen J, Yin FC, Fortuin NJ, Lakatta EG, Weisfeldt ML : Echocardiographic assessment of a normal adult aging population. Circulation 1977; 56: 273–278.
Pearson AC, Gudipati CV, Labovitz AJ : Effects of aging on left ventricular structure and function. Am Heart J 1991; 121: 871–875.
Messerli FH, Frohlich ED, Dreslinski GR, Suarez DH, Aristimuno GG : Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Ann Intern Med 1980; 93: 817–821.
Grundy SM : Small LDL, atherogenic dyslipidemia, and the metabolic syndrome. Circulation 1997; 95: 1–4.
Ward HJ : Uric acid as an independent risk factor in the treatment of hypertension. Lancet 1998; 352: 670–671.
Johnson RJ, Kang D-H, Feig D, et al: Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41: 1183–1190.
Facchini F, Chen Y-DI, Hollenbeck CB, Reaven GM : Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 1991; 266: 3008–3011.
Iwashima Y, Horio T, Kuroda S, et al: Influence of plasma aldosterone on left ventricular geometry and diastolic function in treated essential hypertension. Hypertens Res 2002; 25: 49–56.
Bagnati M, Perugini C, Cau C, Bordone R, Albano E, Bellomo G : When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid. Biochem J 1999; 340: 143–152.
Furumoto T, Saito N, Dong J, et al: Association of cardiovascular risk factors and endothelial dysfunction in Japanese hypertensive patients: Implications for early atherosclerosis. Hypertens Res 2002; 25: 475–480.
Verdecchia P, Reboldi G, Schillaci G, et al: Circulating insulin and insulin-like growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension. Circulation 1999; 100: 1802–1807.
Butler R, Morris AD, Belch JJF, Hill A, Struthers AD : Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 2000; 35: 746–751.
Høieggen A, Alderman MH, Kjeldsen SE, et al: The impact of serum uric acid on cardiovascular outcomes in the LIFE study. Kidney Int 2004; 65: 1041–1049.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kurata, A., Shigematsu, Y. & Higaki, J. Sex-Related Differences in Relations of Uric Acid to Left Ventricular Hypertrophy and Remodeling in Japanese Hypertensive Patients. Hypertens Res 28, 133–139 (2005). https://doi.org/10.1291/hypres.28.133
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.28.133
Keywords
This article is cited by
-
Gender-related differences in the association between serum uric acid and left ventricular mass index in patients with obstructive hypertrophic cardiomyopathy
Biology of Sex Differences (2016)
-
Sex differences in the association between serum uric acid levels and cardiac hypertrophy in patients with chronic kidney disease
Hypertension Research (2014)
-
Early-onset metabolic syndrome in mice lacking the intestinal uric acid transporter SLC2A9
Nature Communications (2014)
-
Uric acid levels, left ventricular mass and geometry in newly diagnosed, never treated hypertension
Journal of Human Hypertension (2011)